Related Experiment Videos
Effect of impaired renal function on tamoxifen
Journal of Surgical Oncology
|December 1, 1984
Summary
This study investigated tamoxifen blood levels in a patient with reduced kidney function and metastatic breast cancer. Results show tamoxifen can be safely administered to patients with renal impairment, as no elevated levels were observed.
Area of Science:
- Oncology
- Pharmacology
- Nephrology
Background:
- Tamoxifen is a crucial endocrine therapy for breast cancer.
- Limited data exists regarding tamoxifen pharmacokinetics in patients with renal impairment.
- High-dose tamoxifen has been associated with serious adverse events.
Observation:
- A single patient with metastatic breast cancer and decreased renal function was monitored.
- Tamoxifen blood levels were assessed during one month of therapy.
- No abnormally elevated tamoxifen concentrations were detected.
Findings:
- Tamoxifen administration in a patient with renal impairment did not lead to excessive blood levels.
- The study provides initial evidence for the safety of tamoxifen in this patient population.
Implications:
- Tamoxifen may be a viable treatment option for breast cancer patients with compromised kidney function.
- Further research is warranted to confirm these findings in a larger cohort.
- This could expand treatment options for breast cancer patients with comorbidities.